Paper35198565
m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Cell-Infiltration Characterization in Head and Neck Cancer.
Yang Q and 5 others. Front Cell Dev Biol, 2021. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Cell-Infiltration Characterization in Head and Neck Cancer. Papers, record 35198565. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35198565
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Cell-Infiltration Characterization in Head and Neck Cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34531875 | Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy. | Front Immunol | 2021 | https://conductscience.org/library/papers/34531875 | PubMed |
| 2 | 23817697 | Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma. | J Cancer Res Clin Oncol | 2013 | https://conductscience.org/library/papers/23817697 | PubMed |
| 3 | 31015515 | Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation. | Nat Commun | 2019 | https://conductscience.org/library/papers/31015515 | PubMed |
| 4 | 31683169 | Immunotherapy for head and neck cancer: Recent advances and future directions. | Oral Oncol | 2019 | https://conductscience.org/library/papers/31683169 | PubMed |
| 5 | 164293 | Methylated nucleotides block 5' terminus of HeLa cell messenger RNA. | Cell | 1975 | https://conductscience.org/library/papers/164293 | PubMed |
| 6 | 28102259 | Elements of cancer immunity and the cancer-immune set point. | Nature | 2017 | https://conductscience.org/library/papers/28102259 | PubMed |
| 7 | 33470439 | m6 A RNA methylation: from mechanisms to therapeutic potential. | EMBO J | 2021 | https://conductscience.org/library/papers/33470439 | PubMed |
| 8 | 23451093 | Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes. | PLoS One | 2013 | https://conductscience.org/library/papers/23451093 | PubMed |
| 9 | 30518868 | m6A-mediated ZNF750 repression facilitates nasopharyngeal carcinoma progression. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/30518868 | PubMed |
| 10 | 27718784 | Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27718784 | PubMed |
| 11 | 20798207 | Screening for oral premalignancy and cancer: what platform and which biomarkers? | Cancer Prev Res (Phila) | 2010 | https://conductscience.org/library/papers/20798207 | PubMed |
| 12 | 15144956 | Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. | Cancer Cell | 2004 | https://conductscience.org/library/papers/15144956 | PubMed |
| 13 | 31308358 | Clinical update on head and neck cancer: molecular biology and ongoing challenges. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31308358 | PubMed |
| 14 | 33807762 | m6A RNA Methylation in Systemic Autoimmune Diseases-A New Target for Epigenetic-Based Therapy? | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/33807762 | PubMed |
| 15 | 29502288 | Immunotherapy for Head and Neck Squamous Cell Carcinoma. | Curr Oncol Rep | 2018 | https://conductscience.org/library/papers/29502288 | PubMed |
| 16 | 26351330 | Immunology and Immunotherapy of Head and Neck Cancer. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/26351330 | PubMed |
| 17 | 29789545 | Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism. | Cell Res | 2018 | https://conductscience.org/library/papers/29789545 | PubMed |
| 18 | 33668218 | New Insights Into Oral Squamous Cell Carcinoma: From Clinical Aspects to Molecular Tumorigenesis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33668218 | PubMed |
| 19 | 4372599 | Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. | Proc Natl Acad Sci U S A | 1974 | https://conductscience.org/library/papers/4372599 | PubMed |
| 20 | 4856346 | Synthesis and turnover of nuclear and cytoplasmic polyadenylic acid in mouse L cells. | J Mol Biol | 1974 | https://conductscience.org/library/papers/4856346 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40176140 | RNA modifications in the tumor microenvironment: insights into the cancer-immunity cycle and beyond. | Exp Hematol Oncol | 2025 | https://conductscience.org/library/papers/40176140 | PubMed |
| 38966068 | Targeting RNA N6-methyladenosine modification-- a novel therapeutic target for HER2- positive gastric cancer. | Front Oncol | 2024 | https://conductscience.org/library/papers/38966068 | PubMed |
| 38709925 | Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38709925 | PubMed |
| 38491545 | m6A methylation modification and immune infiltration analysis in osteonecrosis of the femoral head. | J Orthop Surg Res | 2024 | https://conductscience.org/library/papers/38491545 | PubMed |
| 38166412 | Link between m6A modification and infiltration characterization of tumor microenvironment in lung adenocarcinoma. | Exp Biol Med (Maywood) | 2023 | https://conductscience.org/library/papers/38166412 | PubMed |
| 37221404 | RNA N6-methyladenosine (m6A) modification in HNSCC: molecular mechanism and therapeutic potential. | Cancer Gene Ther | 2023 | https://conductscience.org/library/papers/37221404 | PubMed |
| 36046691 | m6A Regulator-Based Exosomal Gene Methylation Modification Patterns Identify Distinct Microenvironment Characterization and Predict Immunotherapeutic Responses in Colon Cancer. | Oxid Med Cell Longev | 2022 | https://conductscience.org/library/papers/36046691 | PubMed |
Genes35
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35198565
GET https://conductscience.org/api/papers/v1/35198565/references?page=2